Published in Lab Invest on August 01, 1979
Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Am J Pathol (1983) 1.12
Expression of HLA class I antigens on hepatocytes in liver disease. Am J Pathol (1986) 1.10
Chronic hepatitis in chimpanzee carriers of hepatitis B virus: morphologic, immunologic, and viral DNA studies. Proc Natl Acad Sci U S A (1980) 1.07
Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent. Am J Pathol (1999) 1.01
Identification and screening of 416 patients with chronic hepatitis at high risk to develop hepatocellular cancer. Ann Surg (1995) 0.99
Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann Surg (1998) 0.96
Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma. Am J Pathol (1986) 0.95
Morphometric study of hepatocytes containing hepatitis B surface antigen. Am J Pathol (1984) 0.89
Cytokeratin expression in cells of the rodent bile duct developing under normal and pathological conditions. Br J Exp Pathol (1989) 0.88
Animal model of human disease. Chimpanzee carriers of hepatitis B virus. Chimpanzee hepatitis B carriers. Am J Pathol (1981) 0.85
Enzyme patterns in human hepatocellular carcinoma. Am J Pathol (1980) 0.84
Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumor markers defining this tumor. Ann Surg (1985) 0.84
The dynamics of hepatitis B virus infection. Proc Natl Acad Sci U S A (1996) 0.81
Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma. Br J Cancer (1991) 0.80
Antibodies to ribosomes in chronic active hepatitis. Gastroenterology (1979) 12.78
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
A classification of chronic hepatitis. Lancet (1968) 6.07
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med (1991) 4.68
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med (1992) 3.65
Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab (1999) 3.00
Long-term outcomes of persons with Lyme disease. JAMA (2000) 2.96
The canals of Hering and hepatic stem cells in humans. Hepatology (1999) 2.93
Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87
European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J (2010) 2.86
Transmissible agent in non-A, non-B hepatitis. Lancet (1978) 2.78
Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med (1970) 2.71
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.54
Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol (1999) 2.53
Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46
Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41
Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med (1967) 2.41
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32
Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A (1987) 2.24
Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med (1983) 2.16
Hepatic fibrosis. Correlation of biochemical and morphologic investigations. Am J Med (1970) 2.12
Comfrey herb tea-induced hepatic veno-occlusive disease. Am J Med (1989) 2.09
HMB-45 reactivity in adrenal pheochromocytomas. Arch Pathol Lab Med (1992) 2.03
Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci U S A (1976) 2.02
Fulminant hepatic failure. Presumable contribution to halothane. N Engl J Med (1968) 1.99
Hepatitis after exposure to halothane. Ann Intern Med (1969) 1.95
Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology (1987) 1.94
Hepatocarcinogenicity of the woodchuck hepatitis virus. Proc Natl Acad Sci U S A (1987) 1.93
The aetiological agent of cat scratch disease. Lancet (1985) 1.93
Vinyl-chloride-induced liver disease. From idiopathic portal hypertension (Banti's syndrome) to Angiosarcomas. N Engl J Med (1975) 1.92
Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology. Am J Pathol (1978) 1.92
Antigen detection test for streptococcal pharyngitis: evaluation of sensitivity with respect to true infections. J Pediatr (1986) 1.89
Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial. Gastroenterology (1985) 1.86
The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology (1992) 1.85
Identification of bipotential progenitor cells in human liver development. Hepatology (1996) 1.84
Micronitrous acid extraction-coagglutination test for rapid diagnosis of streptococcal pharyngitis. J Clin Microbiol (1983) 1.79
Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology (1997) 1.77
Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74
Effect of antibiotic therapy on the clinical course of streptococcal pharyngitis. J Pediatr (1985) 1.73
Hepatic 'stem cell' malignancies in adults: four cases. Histopathology (2003) 1.73
Electron microscopy and immunoelectronmicroscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am J Pathol (1974) 1.70
Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations. Hepatology (1981) 1.67
Cytoplasmic hepatitis B antigen in "ground-glass" hepatocytes of carriers. Arch Pathol (1973) 1.65
Antimitochondrial antibodies in jaundice following drug administration. JAMA (1969) 1.61
Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol (1990) 1.60
Telomerase activity in precancerous hepatic nodules. Cancer (1998) 1.59
Latex agglutination tests for rapid identification of group A streptococci directly from throat swabs. J Pediatr (1984) 1.56
Fat-storing cells (lipocytes) in human liver. Arch Pathol (1966) 1.55
Cholestasis is the result of hypoactive hypertrophic smooth endoplasmic reticulum in the hepatocyte. Lancet (1969) 1.54
Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin Infect Dis (1992) 1.51
Clinical pathologic correlation in viral hepatitis. The effect of the virus on the liver. Am J Pathol (1975) 1.50
Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet (1990) 1.49
Immune processes in the pathogenesis of liver disease. Ann N Y Acad Sci (1965) 1.46
Antibodies to cytoplasmic antigens in primary biliary cirrhosis and chronic active hepatitis. J Lab Clin Med (1967) 1.46
Culturing of throat swabs: end of an era? J Pediatr (1985) 1.45
Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology (1987) 1.45
Detection of hepatitis B and hepatitis C viral sequences in fulminant hepatic failure of unknown etiology. Am J Clin Pathol (1995) 1.43
Aggravation of hepatic lesions in mice by in vivo localization of immune complexes (Auer hepatitis). Am J Pathol (1965) 1.43
Molecular and cellular pathology of hepatitis B. Lab Invest (1985) 1.43
Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42
The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis. Arch Pathol Lab Med (1998) 1.42
HLA-DR expression in bile duct damage in hepatitis C. Mod Pathol (1993) 1.42
Alterations of liver and spleen among workers exposed to vinyl chloride. Ann N Y Acad Sci (1975) 1.42
Pathologic aspects of cirrhosis. A review. Am J Pathol (1977) 1.41
Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology (1989) 1.39
Pathophysiology of cholestasis. Hum Pathol (1970) 1.39
Ground squirrel hepatitis virus infection. Hepatology (1983) 1.36
Immune complexes in hepatocytic nuclei of HB ag-positive chronic hepatitis. N Engl J Med (1976) 1.35
Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction. Gastroenterology (1972) 1.34
Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology (1980) 1.33
Hepatic drug reactions. Prog Liver Dis (1972) 1.33
Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis (1983) 1.32
Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32
Chronic liver injury induced by immunologic reactions. Cirrhosis following immunization with heterologous sera. Am J Pathol (1966) 1.31
Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. Am J Surg Pathol (1998) 1.30
Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside. Hepatology (1981) 1.29
Non-A, non-B hepatitis-related hepatocellular carcinoma in a chimpanzee. J Med Primatol (1988) 1.29
Nonsuppurative destructive chronic cholangitis and chronic hepatitis. Prog Liver Dis (1970) 1.28
The vocabulary of chronic hepatitis. N Engl J Med (1971) 1.26
Identification of bipotential progenitor cells in human liver regeneration. Lab Invest (1996) 1.26
Liver-directed gene transfer in non-human primates. Hum Gene Ther (1997) 1.25
Diagnosis of group A beta-hemolytic streptococcal pharyngitis. Use of antigen detection tests. Diagn Microbiol Infect Dis (1986) 1.24
Hepatocellular hyalin in cholestasis and cirrhosis: its diagnostic significance. Gastroenterology (1973) 1.23
Transfection of HepG2 cells with infectious hepatitis C virus genome. Am J Pathol (1997) 1.23
Studies of prototype live hepatitis A virus vaccines in primate models. J Infect Dis (1988) 1.23
Liver disease associated with duck hepatitis B virus infection of domestic ducks. Proc Natl Acad Sci U S A (1984) 1.22